Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0N0AJ
|
|||
| Former ID |
DIB001425
|
|||
| Drug Name |
Double mutant heat-labile toxin
|
|||
| Synonyms |
DmLT; LT(R192G/L211A); Double mutant heat-labile toxin (recombinant vaccine, ETEC infection); Double mutant heat-labile toxin (recombinant vaccine, ETEC infection), NIAID/PATH/Tulane University
Click to Show/Hide
|
|||
| Indication | Escherichia coli infection [ICD-11: 1A03; ICD-10: A04, A04.4] | Phase 1 | [1] | |
| Company |
Tulane University
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Safety and immunogenicity of a single oral dose of recombinant double mutant heat-labile toxin derived from enterotoxigenic Escherichia coli. Clin Vaccine Immunol. 2013 Nov;20(11):1764-70. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.